Remove Acquisition Remove Capital Remove Marketing Remove Torrance
article thumbnail

Tocagen, Forte Biosciences In Merger

socalTECH

The newly merged company will operate under the name Forte Biosciences, and trade on the Nasdaq Capital Market as FBRX. The merged company will focus on Forte's late-stage clinical program for treating atopic dermatitis. READ MORE>>.

Torrance 113